ArticleFrontiers in pharmacology2025
Empagliflozin targeting STAT3/Akt/Nrf2 axis promoting diabetic wound healing in rat model.
Rania Magadmi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
this papercites it